|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16 |
c.4903G>A |
5022G>A |
p.E1635K |
0.087187479 |
3 - Uncertain |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
4.530327501 |
1.033092037 |
- |
4.680245267 |
- |
BRCA1_00521 |
16 |
c.4910C>T |
5029C>T |
p.P1637L |
0.00004 |
1 - Not pathogenic or of no clinical significance |
Easton et al. 2007 |
Tavtigian et al. 2008 |
0.02 |
0.01 |
0.00 |
0.02 |
0.347 |
- |
0.0148 |
0.398 |
- |
0.00204 |
- |
BRCA1_00090 |
16 |
c.4933A>G |
5052A>G |
p.R1645G |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.779710926 |
1.033092037 |
- |
0.805513149 |
- |
BRCA1_00522 |
16 |
c.4934G>T |
5053G>T |
p.R1645K |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.594053557 |
1.033092037 |
- |
0.613712 |
- |
BRCA1_00523 |
16 |
c.4941C>A |
5060C>A |
p.N1647K |
0.009213543 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
0.1709 |
3.31 |
0.779710926 |
1.033092037 |
- |
0.455661873 |
- |
BRCA1_00524 |
16 |
c.4955T>A |
5074T>A |
p.M1652R |
- |
- |
Parsons et al 2019 |
- |
0.66 |
- |
0.02 |
0.66 |
- |
1.36 |
0.758063525 |
1.033092037 |
- |
1.065083172 |
- |
BRCA1_00525 |
16 |
c.4955T>C |
5074T>C |
p.M1652T |
0.00011 |
1 - Not pathogenic or of no clinical significance |
Easton et al. 2007 |
Tavtigian et al. 2008 |
0.29 |
0.01 |
0.00 |
0.29 |
0.012 |
- |
0.0182 |
1.23 |
- |
0.00027 |
- |
BRCA1_00117 |
16 |
c.4956G>A |
5075G>A |
p.M1652I |
0.00001 |
1 - Not pathogenic or of no clinical significance |
Osorio et al. 2007 |
Tavtigian et al. 2008 |
0.03 |
0.01 |
0.00 |
0.03 |
- |
0.00268 |
0.18 |
- |
- |
0.00048 |
- |
BRCA1_00107 |
16 |
c.4957G>A |
5076G>A |
p.V1653M |
- |
- |
Parsons et al 2019 |
- |
0.03 |
- |
0.02 |
0.03 |
0.9973 |
- |
- |
- |
- |
0.9973 |
- |
BRCA1_00526 |
16 |
c.4963T>C |
5082T>C |
p.S1655P |
- |
- |
Parsons et al 2019 |
- |
0.03 |
- |
0.02 |
0.03 |
- |
0.64 |
- |
- |
- |
0.64 |
- |
BRCA1_00527 |
16 |
c.4964C>T |
5083C>T |
p.S1655C |
0.926690175 |
3 - Uncertain |
Parsons et al 2019 |
- |
0.29 |
- |
0.02 |
0.29 |
8.3757 |
3.694672 |
0.907023801 |
1.102597599 |
- |
30.94801002 |
- |
BRCA1_00528 |
16 |
c.4985T>C |
5104T>C |
p.F1662S |
0.00021 |
1 - Not pathogenic or of no clinical significance |
Easton et al. 2007 |
Tavtigian et al. 2008 |
0.03 |
0.04 |
0.00 |
0.04 |
1 |
- |
1.44 |
0.00355 |
- |
0.00511 |
- |
BRCA1_00091 |
16 |
c.4986+3G>C |
IVS16+3G>C |
- |
0.517634545 |
3 - Uncertain |
Parsons et al 2019 |
- |
- |
0.97 |
0.02 |
0.97 |
7.93035E-05 |
418.5085524 |
- |
- |
- |
0.033189184 |
- |
BRCA1_00410 |
16 |
c.4986+5G>A |
IVS16+5G>A |
- |
- |
- |
Parsons et al 2019 |
- |
- |
0.97 |
0.02 |
0.97 |
0.9633 |
- |
- |
- |
- |
0.9633 |
- |
BRCA1_00718 |
16 |
c.4986+6T>G |
IVS16+6T>G |
- |
0.99999856 |
5 - Pathogenic |
Parsons et al 2019 |
- |
- |
0.97 |
0.02 |
0.97 |
18.94466598 |
1134.071346 |
- |
- |
- |
21484.60285 |
- |
BRCA1_00415 |
16 |
c.4986+117A>T |
IVS16+117A>T |
- |
0.006890961 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.02 |
- |
0.34 |
- |
- |
- |
0.34 |
- |
BRCA1_00529 |
16 |
c.4987-11T>C |
IVS16-11T>C |
- |
0.032393125 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
- |
0.34 |
0.02 |
0.34 |
- |
- |
0.060889287 |
1.067279157 |
- |
0.064985867 |
- |
BRCA1_00530 |
16 |
c.4987-2A>G |
IVS16-2A>G |
- |
0.998471334 |
5 - Pathogenic |
Parsons et al 2019 |
- |
- |
0.97 |
0.02 |
0.97 |
1.9876 |
9.698 |
- |
1.048 |
- |
20.20098055 |
- |
BRCA1_00420 |
17 |
c.4987-20A>G |
IVS16-20A>G |
- |
0.000 |
1 - Not pathogenic or of no clinical significance |
Easton et al. 2007 |
Vallee et al. 2016 |
- |
0.34 |
0.00 |
0.34 |
1 |
- |
2.69E-03 |
2.04E-04 |
- |
5.50E-07 |
- |
BRCA1_00140 |
17 |
c.4987A>T |
5106A>T |
p.M1663V |
0.130991298 |
3 - Uncertain |
Parsons et al 2019 |
- |
0.03 |
0.34 |
0.02 |
0.34 |
- |
- |
0.283233308 |
1.033092037 |
- |
0.292606075 |
- |
BRCA1_00431 |
17 |
c.4991T>C |
5110T>C |
p.L1664P |
0.000 |
1 - Not pathogenic or of no clinical significance |
Whiley et al., 2014 |
Tavtigian et al. 2008 |
0.03 |
0.02 |
0.00 |
0.03 |
0.01 |
- |
0.03 |
1.29 |
- |
3.87E-04 |
- |
BRCA1_00131 |
17 |
c.5017_5019del |
5136delCAC |
- |
0.4790721 |
3 - Uncertain |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.03 |
17.5575046 |
1.69360041 |
- |
- |
- |
29.73539699 |
- |
BRCA1_00690 |
17 |
c.5024C>T |
5143C>T |
p.T1675S |
3.09269E-05 |
1 - Not pathogenic or of no clinical significance |
Parsons et al 2019 |
- |
0.03 |
- |
0.02 |
0.03 |
0.0025 |
0.4 |
- |
- |
- |
0.001 |
- |
BRCA1_00531 |
17 |
c.5036T>C |
5155T>C |
p.L1679P |
0.012219959 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.03 |
- |
0.02 |
0.03 |
- |
0.4 |
- |
- |
- |
0.4 |
- |
BRCA1_00532 |
17 |
c.5044G>A |
5163G>A |
p.E1682K |
0.00010 |
1 - Not pathogenic or of no clinical significance |
Easton et al. 2007 |
Tavtigian et al. 2008 |
0.03 |
0.01 |
0.00 |
0.03 |
1 |
- |
1 |
0.00316 |
- |
0.00316 |
- |
BRCA1_00092 |
|
DNA change |
|

 | |
|
|
|
|
Key Observational Reference |
 |

 | |
|
Missense analysis Prior P |
 |

 | |
|
|
|
|
|
|
|
|
|
|
|
17 |
c.5045A>T |
5164A>T |
p.E1682G |
- |
- |
Parsons et al 2019 |
- |
0.03 |
- |
0.02 |
0.03 |
- |
- |
0.843402425 |
1.033092037 |
- |
0.871312329 |
- |
BRCA1_00533 |
17 |
c.5053A>G |
5172A>G |
p.T1685A |
0.9952 |
5 - Definitely pathogenic |
Easton et al. 2007 |
Tavtigian et al. 2008 |
0.66 |
0.01 |
0.00 |
0.66 |
1 |
- |
100 |
1.07 |
- |
107 |
- |
BRCA1_00042 |
17 |
c.5054C>T |
5173C>T |
p.T1685I |
0.9983 |
5 - Definitely pathogenic |
Easton et al. 2007 |
Tavtigian et al. 2008 |
0.81 |
0.01 |
0.00 |
0.81 |
1 |
- |
125.89 |
1.1 |
- |
138.479 |
- |
BRCA1_00050 |
17 |
c.5062_5064del (Reported 2 times) |
5181del3 |
p.V1688del |
0.99312 |
5 - Definitely pathogenic |
Easton et al. 2007 |
Easton et al. 2007 |
0.35 |
0.02 |
0.00 |
0.35 |
16.98 |
- |
13.49 |
1.17 |
- |
268.00 |
- |
BRCA1_00156 |
17 |
c.5066T>G |
5185T>G |
p.M1689R |
0.9889 |
4 - Likely pathogenic |
Easton et al. 2007 |
Tavtigian et al. 2008 |
0.66 |
0.01 |
0.00 |
0.66 |
1 |
- |
30.9 |
1.48 |
- |
45.732 |
- |
BRCA1_00041 |
17 |
c.5068A>C |
5187A>C |
p.K1690Q |
0.012219959 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.03 |
- |
0.02 |
0.03 |
- |
0.4 |
- |
- |
- |
0.4 |
- |
BRCA1_00534 |
17 |
c.5071A>G |
5190A>G |
p.T1691A |
- |
- |
Parsons et al 2019 |
- |
0.66 |
- |
0.02 |
0.66 |
- |
- |
0.64538081 |
1.033092037 |
- |
0.666737775 |
- |
BRCA1_00692 |
17 |
c.5072C>A |
5191C>A |
p.T1691K |
- |
- |
Parsons et al 2019 |
- |
0.81 |
0.04 |
0.02 |
0.81 |
- |
1.264 |
- |
- |
- |
1.264 |
- |
BRCA1_00693 |
17 |
c.5072C>T |
5191C>T |
p.T1691R |
- |
- |
Parsons et al 2019 |
- |
0.81 |
0.34 |
0.02 |
0.81 |
- |
- |
0.810565152 |
1.340451569 |
- |
1.08652333 |
- |
BRCA1_00432 |
17 |
c.5074G>C |
5193G>C |
p.D1692H |
0.996158521 |
5 - Pathogenic |
Parsons et al 2019 |
- |
0.81 |
0.97 |
0.02 |
0.97 |
1.911397392 |
3.73 |
0.900967798 |
1.248562982 |
- |
8.020095591 |
- |
BRCA1_00717 |
17 |
c.5074G>T |
5193G>T |
p.D1692N |
0.941360096 |
3 - Uncertain |
Parsons et al 2019 |
- |
0.81 |
0.97 |
0.02 |
0.97 |
- |
- |
0.480588126 |
1.033092037 |
- |
0.496491767 |
- |
BRCA1_00441 |
17 |
c.5074+1G>A |
IVS17+1G>A |
- |
1.000 |
5 - Definitely pathogenic |
Easton et al. 2007 |
Vallee et al. 2016 |
- |
0.97 |
0.00 |
0.97 |
1 |
1 |
160.57 |
1.22 |
- |
195.90 |
- |
BRCA1_00122 |
17 |
c.5074+1G>T |
IVS17+1G>T |
- |
0.998991527 |
5 - Pathogenic |
Parsons et al 2019 |
- |
- |
0.97 |
0.02 |
0.97 |
13.9234 |
1.691648 |
1.179708109 |
1.102597599 |
- |
30.63704728 |
- |
BRCA1_00438 |
17 |
c.5074+2T>C |
IVS17+2T>C |
- |
0.999563022 |
5 - Pathogenic |
Parsons et al 2019 |
- |
- |
0.97 |
0.02 |
0.97 |
2.4319 |
3.73 |
7.307473789 |
1.067279157 |
- |
70.74566595 |
- |
BRCA1_00536 |
17 |
c.5074+3A>G |
IVS17+3A>G |
- |
- |
- |
Parsons et al 2019 |
- |
- |
0.97 |
0.02 |
0.97 |
1.7629 |
- |
- |
- |
- |
1.7629 |
- |
BRCA1_00439 |
17 |
c.5074+6C>G |
IVS17+6C>G |
- |
5.98132E-08 |
1 - Not pathogenic or of no clinical significance |
Parsons et al 2019 |
- |
- |
0.04 |
0.02 |
0.04 |
0.004977646 |
0.000244592 |
0.700353645 |
1.68354305 |
- |
0.00000143552 |
- |
BRCA1_00715 |
17 |
c.5074+23A>G |
IVS17+23A>G |
- |
0.003984064 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.02 |
- |
0.196 |
- |
- |
- |
0.196 |
- |
BRCA1_00535 |
18 |
c.5075-9A>T |
IVS17-9A>T |
- |
0.000 |
1 - Not pathogenic or of no clinical significance |
Easton et al. 2007 |
Vallee et al. 2016 |
- |
0.04 |
0.00 |
0.04 |
1 |
- |
1.23 |
3.72E-03 |
- |
4.57E-03 |
- |
BRCA1_00141 |
18 |
c.5076T>G |
5195T>G |
p.D1692E |
0.887756117 |
3 - Uncertain |
Parsons et al 2019 |
- |
0.66 |
0.34 |
0.02 |
0.66 |
- |
- |
3.817578216 |
1.067279157 |
- |
4.074421662 |
- |
BRCA1_00537 |
18 |
c.5078_5080del |
5197del3 |
p.A1693del |
0.238379316 |
3 - Uncertain |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.03 |
3.6431 |
9.9856 |
0.269275008 |
1.033092037 |
- |
10.11999548 |
- |
BRCA1_00224 |
18 |
c.5085T>A |
5204T>A |
p.F1695L |
- |
- |
Parsons et al 2019 |
- |
0.03 |
- |
0.02 |
0.03 |
- |
- |
0.779710926 |
1.033092037 |
- |
0.805513149 |
- |
BRCA1_00538 |
18 |
c.5089T>C |
5208T>C |
p.C1697R |
0.99986659 |
5 - Pathogenic |
Parsons et al 2019 |
- |
0.81 |
- |
0.02 |
0.81 |
730.6336757 |
2.4061544 |
- |
- |
- |
1758.017434 |
- |
BRCA1_00539 |
18 |
c.5095C>T |
5214C>T |
p.R1699W |
1.0000 |
5 - Definitely pathogenic |
Easton et al. 2007 |
Tavtigian et al. 2008 |
0.81 |
0.01 |
0.00 |
0.81 |
1 |
- |
21877.62 |
1.82 |
- |
3.98173E+4 |
- |
BRCA1_00046 |
18 |
c.5096G>A |
5215G>A |
p.R1699Q |
0.8853 |
3 - Uncertain |
Goldgar et al. 2004 |
Tavtigian et al. 2008 |
0.66 |
0.01 |
0.00 |
0.66 |
2.84 |
- |
- |
1.4 |
- |
3.976 |
This variant is considered pathogenic with reduced penetrance. Additional families were collected for relative risk estimates (Moghadasi et al 2017) but the standard co-segregation analysis has not been updated |
BRCA1_00002 |
18 |
c.5096G>T |
5215G>T |
p.R1699Q |
- |
- |
Parsons et al 2019 |
- |
0.81 |
- |
0.02 |
0.81 |
- |
- |
0.731999383 |
1.033092037 |
- |
0.756222734 |
- |
BRCA1_00541 |
|
DNA change |
|

 | |
|
|
|
|
Key Observational Reference |
 |

 | |
|
Missense analysis Prior P |
 |

 | |
|
|
|
|
|
|
|
|
|
|
|
18 |
c.5099C>T |
5218C>T |
p.T1700R |
- |
- |
Parsons et al 2019 |
- |
0.81 |
- |
0.02 |
0.81 |
1.3208 |
0.49 |
- |
- |
- |
0.647192 |
- |
BRCA1_00542 |
18 |
c.5112T>A |
5231T>A |
p.F1704L |
- |
- |
Parsons et al 2019 |
- |
0.29 |
- |
0.02 |
0.29 |
- |
- |
0.950879643 |
1.1390848 |
- |
1.083132548 |
- |
BRCA1_00544 |
18 |
c.5114T>C |
5233T>C |
p.L1705P |
0.342267729 |
3 - Uncertain |
Parsons et al 2019 |
- |
0.03 |
- |
0.02 |
0.03 |
3.8153 |
4.41 |
- |
- |
- |
16.825473 |
- |
BRCA1_00545 |
18 |
c.5117G>A |
5236G>A |
p.G1706E |
0.9996 |
5 - Definitely pathogenic |
Easton et al. 2007 |
Tavtigian et al. 2008 |
0.81 |
0.02 |
0.00 |
0.81 |
1.95 |
- |
223.87 |
1.35 |
- |
589.338 |
- |
BRCA1_00048 |
18 |
c.5117G>C |
5236G>C |
p.G1706A |
0.00005 |
1 - Not pathogenic or of no clinical significance |
Lovelock et al. 2006 |
Tavtigian et al. 2008 |
0.66 |
0.01 |
0.00 |
0.66 |
0.00044 |
0.058 |
- |
- |
- |
2.55200E-5 |
- |
BRCA1_00109 |
18 |
c.5117G>T |
5236G>T |
p.G1706E |
- |
- |
Parsons et al 2019 |
- |
0.81 |
- |
0.02 |
0.81 |
8.8767 |
0.16 |
- |
- |
- |
1.420272 |
- |
BRCA1_00546 |
18 |
c.5123C>A |
5242C>A |
p.A1708E |
1.0000 |
5 - Definitely pathogenic |
Easton et al. 2007 |
Tavtigian et al. 2008 |
0.81 |
0.01 |
0.00 |
0.81 |
1 |
- |
1.66E+11 |
12.59 |
- |
2.08994E+12 |
- |
BRCA1_00045 |
18 |
c.5123C>T |
5242C>T |
p.A1708V |
0.7498 |
3 - Uncertain |
Chenevix-Trench et al. 2006 |
Tavtigian et al. 2008 |
0.81 |
0.01 |
0.00 |
0.81 |
0.227 |
2.95 |
- |
1.05 |
- |
0.70313 |
- |
BRCA1_00030 |
18 |
c.5129G>A |
5248G>A |
p.G1710E |
- |
- |
Parsons et al 2019 |
- |
0.03 |
- |
0.02 |
0.03 |
- |
0.64 |
- |
- |
- |
0.64 |
- |
BRCA1_00547 |
18 |
c.5143A>C |
5262A>C |
p.S1715R |
0.9948 |
5 - Definitely pathogenic |
Easton et al. 2007 |
Tavtigian et al. 2008 |
0.81 |
0.01 |
0.00 |
0.81 |
1 |
- |
36.31 |
1.23 |
- |
44.6613 |
- |
BRCA1_00051 |
18 |
c.5143A>T |
5262A>T |
p.S1715G |
0.928747653 |
3 - Uncertain |
Parsons et al 2019 |
- |
0.81 |
- |
0.02 |
0.81 |
- |
- |
2.959566636 |
1.033092037 |
- |
3.057504725 |
- |
BRCA1_00548 |
18 |
c.5144G>A |
5263G>A |
p.S1715N |
0.999493668 |
5 - Pathogenic |
Parsons et al 2019 |
- |
0.66 |
- |
0.02 |
0.66 |
57.86 |
3.73 |
3.631450851 |
1.297514181 |
- |
1016.903038 |
- |
BRCA1_00694 |
18 |
c.5152+1G>T |
IVS18+1G>T |
- |
1.000 |
5 - Definitely pathogenic |
Spurdle et al. 2008 |
Vallee et al. 2016 |
- |
0.97 |
0.00 |
0.97 |
12.87 |
7.56E+03 |
- |
1.15 |
- |
1.12E+05 |
- |
BRCA1_00142 |
18 |
c.5152+2dup |
IVS18+2insT |
- |
- |
- |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.97 |
- |
- |
1.304022966 |
1.033092037 |
- |
1.347175743 |
- |
BRCA1_00444 |
18 |
c.5152+7A>G |
IVS18+7A>G |
- |
- |
- |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.02 |
- |
- |
0.893504299 |
1.033092037 |
- |
0.923072177 |
- |
BRCA1_00549 |
18 |
c.5153-26A>G |
IVS18-26A>G |
- |
- |
- |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.02 |
0.385044263 |
3.73 |
- |
- |
- |
1.436215101 |
- |
BRCA1_00550 |
18 |
c.5153-5T>C |
IVS18-5T>C |
- |
0.016420032 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
- |
0.04 |
0.02 |
0.04 |
- |
- |
0.387825666 |
1.033092037 |
- |
0.400659608 |
- |
BRCA1_00552 |
18 |
c.5153-3T>C |
IVS18-3T>C |
- |
0.006964376 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
- |
0.34 |
0.02 |
0.34 |
- |
- |
0.011951607 |
1.1390848 |
- |
0.013613894 |
- |
BRCA1_00551 |
18 |
c.5153-1G>A |
IVS18-1G>A |
- |
0.991890533 |
5 - Pathogenic |
Parsons et al 2019 |
- |
- |
0.97 |
0.02 |
0.97 |
- |
- |
3.111622389 |
1.215721465 |
- |
3.78286613 |
- |
BRCA1_00449 |
19 |
c.5153-13A>G |
IVS18-13A>G |
- |
0.000 |
1 - Not pathogenic or of no clinical significance |
Easton et al. 2007 |
Vallee et al. 2016 |
- |
0.04 |
0.00 |
0.04 |
0.10 |
- |
0.41 |
3.80E-03 |
- |
1.48E-04 |
- |
BRCA1_00143 |
19 |
c.5153-6C>A |
IVS18-6C>A |
- |
0.000 |
1 - Not pathogenic or of no clinical significance |
Easton et al. 2007 |
Vallee et al. 2016 |
- |
0.34 |
0.00 |
0.34 |
1 |
- |
7.24E-03 |
3.55E-03 |
- |
2.57E-05 |
- |
BRCA1_00145 |
19 |
c.5153-1G>C |
IVS18-1G>C |
- |
0.999 |
5 - Definitely pathogenic |
Easton et al. 2007 |
Vallee et al. 2016 |
- |
0.97 |
0.00 |
0.97 |
1 |
- |
20.42 |
1.15 |
- |
23.44 |
- |
BRCA1_00144 |
19 |
c.5153G>C |
5272G>C |
p.W1718S |
0.934056846 |
3 - Uncertain |
Parsons et al 2019 |
- |
0.81 |
0.34 |
0.02 |
0.81 |
- |
- |
3.216126773 |
1.033092037 |
- |
3.32255496 |
- |
BRCA1_00695 |
19 |
c.5158A>G |
5277A>G |
p.T1720A |
0.00000 |
1 - Not pathogenic or of no clinical significance |
Easton et al. 2007 |
Tavtigian et al. 2008 |
0.03 |
0.01 |
0.00 |
0.03 |
0.00001 |
- |
5.89E-07 |
3.09 |
- |
1.82001E-11 |
- |
BRCA1_00093 |
19 |
c.5165C>A |
5284C>A |
p.S1722Y |
- |
- |
Parsons et al 2019 |
- |
0.29 |
- |
0.02 |
0.29 |
4.84239096 |
0.16 |
- |
- |
- |
0.774782554 |
- |
BRCA1_00553 |
|
DNA change |
|

 | |
|
|
|
|
Key Observational Reference |
 |

 | |
|
Missense analysis Prior P |
 |

 | |
|
|
|
|
|
|
|
|
|
|
|
19 |
c.5185C>G |
5304C>G |
p.L1729V |
0.056665864 |
3 - Uncertain |
Parsons et al 2019 |
- |
0.29 |
- |
0.02 |
0.3 |
- |
- |
0.135673096 |
1.033092037 |
- |
0.140162795 |
- |
BRCA1_00554 |
19 |
c.5189A>G |
5308A>G |
p.N1730S |
0.005656399 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.03 |
- |
0.02 |
0.03 |
- |
0.64 |
0.269275008 |
1.067279157 |
- |
0.183930626 |
- |
BRCA1_00555 |
19 |
c.5189A>T |
5308A>T |
p.N1730S |
0.004056224 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.03 |
- |
0.02 |
0.03 |
- |
- |
0.127467244 |
1.033092037 |
- |
0.131685395 |
- |
BRCA1_00556 |
19 |
c.5193+1G>A |
IVS19+1G>A |
- |
0.98561825 |
4 - Likely Pathogenic |
Parsons et al 2019 |
- |
- |
0.97 |
0.02 |
0.97 |
1.2692 |
1.67 |
- |
- |
- |
2.119564 |
- |
BRCA1_00557 |
19 |
c.5194-30T>C |
IVS19-30T>C |
- |
- |
- |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.02 |
- |
0.57 |
- |
- |
- |
0.57 |
- |
BRCA1_00560 |
19 |
c.5194-18G>T |
IVS19-18G>T |
- |
0.014399979 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
- |
0.04 |
0.02 |
0.04 |
- |
- |
0.279189646 |
1.255952165 |
- |
0.35064884 |
- |
BRCA1_00559 |
19 |
c.5194-13T>C |
IVS19-13T>C |
- |
- |
- |
Parsons et al 2019 |
- |
- |
0.34 |
0.02 |
0.34 |
- |
1.36 |
- |
- |
- |
1.36 |
- |
BRCA1_00558 |
19 |
c.5194-12G>A |
IVS19-12G>A |
- |
0.995 |
5 - Definitely pathogenic |
Easton et al. 2007 |
Vallee et al. 2016 |
0.02 |
0.34 |
0.00 |
0.34 |
0.0087 |
1 |
33,113 |
1.26 |
- |
362.99 |
- |
BRCA1_00123 |
20 |
c.5198A>G |
5317A>G |
p.D1733G |
0.00057653 |
1 - Not pathogenic or of no clinical significance |
Parsons et al 2019 |
- |
0.03 |
- |
0.02 |
0.03 |
- |
- |
0.010724073 |
1.739254919 |
- |
0.018651896 |
- |
BRCA1_00561 |
20 |
c.5207T>C |
5326T>C |
p.V1736A |
0.999 |
5 - Definitely pathogenic |
Domchek et al. 2013 |
Vallee et al. 2016 |
0.81 |
0.02 |
0.00 |
0.81 |
234 |
- |
- |
- |
- |
234 |
- |
BRCA1_00094 |
20 |
c.5207T>G |
5326T>G |
p.V1736G |
0.968449731 |
4 - Likely Pathogenic |
Parsons et al 2019 |
- |
0.81 |
- |
0.02 |
0.81 |
- |
- |
6.530185999 |
1.102597599 |
- |
7.200167403 |
- |
BRCA1_00562 |
20 |
c.5212G>A |
5331G>A |
p.G1738R |
0.9980 |
5 - Definitely pathogenic |
Easton et al. 2007 |
Tavtigian et al. 2008 |
0.81 |
0.01 |
0.00 |
0.81 |
1 |
- |
87.1 |
1.32 |
- |
114.972 |
- |
BRCA1_00043 |
20 |
c.5213G>A |
5332G>A |
p.G1738E |
0.981287815 |
4 - Likely Pathogenic |
Parsons et al 2019 |
- |
0.81 |
- |
0.02 |
0.81 |
1.176157506 |
- |
8.887506689 |
1.176779436 |
- |
12.30100219 |
- |
BRCA1_00564 |
20 |
c.5213_5215del |
5331del3 |
- |
- |
- |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.81 |
- |
- |
1.189189682 |
1.176779436 |
- |
1.399413963 |
- |
BRCA1_00563 |
20 |
c.5216A>G |
5335A>G |
p.D1739G |
- |
- |
Parsons et al 2019 |
- |
0.81 |
- |
0.02 |
0.81 |
1.614087 |
- |
- |
- |
- |
1.614087 |
- |
BRCA1_00565 |
20 |
c.5216A>T |
5335A>T |
p.D1739G |
0.966267209 |
4 - Likely Pathogenic |
Parsons et al 2019 |
- |
0.81 |
- |
0.02 |
0.81 |
0.8205 |
- |
7.926764441 |
1.033092037 |
- |
6.719137863 |
Likely Pathogenic* |
BRCA1_00566 |
20 |
c.5217T>G |
5336T>G |
p.D1739E |
0.883952167 |
3 - Uncertain |
Parsons et al 2019 |
- |
0.66 |
- |
0.02 |
0.66 |
- |
- |
3.798286308 |
1.033092037 |
- |
3.92397934 |
- |
BRCA1_00567 |
20 |
c.5243G>A |
5362G>A |
p.G1748D |
0.979967531 |
4 - Likely Pathogenic |
Parsons et al 2019 |
- |
0.81 |
- |
0.02 |
0.81 |
3.8 |
3.16 |
0.924987999 |
1.033092037 |
- |
11.47481761 |
- |
BRCA1_00568 |
20 |
c.5252G>A |
5371G>A |
p.R1751Q |
0.00021 |
1 - Not pathogenic or of no clinical significance |
Easton et al. 2007 |
Tavtigian et al. 2008 |
0.03 |
0.01 |
0.00 |
0.03 |
2 |
- |
0.00219 |
1.55 |
- |
0.00679 |
- |
BRCA1_00095 |
20 |
c.5252G>C |
5371G>C |
p.R1751P |
0.868970205 |
3 - Uncertain |
Parsons et al 2019 |
- |
0.66 |
- |
0.02 |
0.66 |
- |
- |
3.09850901 |
1.102597599 |
- |
3.416408595 |
- |
BRCA1_00569 |
20 |
c.5254G>A |
5373G>A |
p.A1752T |
- |
- |
Parsons et al 2019 |
- |
0.03 |
- |
0.02 |
0.03 |
1.1148 |
- |
- |
- |
- |
1.1148 |
- |
BRCA1_00570 |
20 |
c.5258G>C |
5377G>C |
p.R1753T |
0.948012744 |
3 - Uncertain |
Parsons et al 2019 |
- |
0.81 |
- |
0.02 |
0.81 |
- |
- |
4.007816569 |
1.067279157 |
- |
4.277459091 |
- |
BRCA1_00571 |
20 |
c.5276A>G |
5395A>G |
p.K1759R |
- |
- |
Parsons et al 2019 |
- |
0.03 |
0.34 |
0.02 |
0.34 |
- |
- |
0.718851415 |
1.033092037 |
- |
0.742639673 |
- |
BRCA1_00572 |
20 |
c.5277+1G>A |
IVS20+1G>A |
- |
1.000 |
5 - Definitely pathogenic |
Easton et al. 2007 |
Vallee et al. 2016 |
- |
0.97 |
0.00 |
0.97 |
1 |
- |
1.29E+11 |
3.31 |
- |
4.27E+11 |
- |
BRCA1_00146 |
20 |
c.5277+1_5277+6del |
IVS20+1del6 |
- |
0.998021647 |
5 - Pathogenic |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.97 |
- |
- |
15.10242302 |
1.033092037 |
- |
15.60219297 |
- |
BRCA1_00573 |